Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Sign Up to like & getrecommendations! Published in 2018 at "Clinics in liver disease"
DOI: 10.1016/j.cld.2017.08.013
Abstract: This review discusses completed phase II randomized clinical trials with high-quality published results for compounds that demonstrate effects on nonalcoholic steatohepatitis histology (obeticholic acid, elafibranor, and liraglutide). The authors also review the available preliminary data… read more here.
Keywords: emerging treatments; liver disease; treatments nonalcoholic; nonalcoholic steatohepatitis ... See more keywords